Carson Wealth (CWM LLC)’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-13	Closed	–	–	4652
2023 Q3	$0	Buy	13 +2	+18%	+$23	﹤0.01%	4634
2023 Q2	$0	Sell	11 -83	-88%	-$1.16K	﹤0.01%	4557
2023 Q1	$1K	Buy	+94	New	+$1.63K	﹤0.01%	3990
2022 Q4	–	Sell	-9	Closed	–	–	4337
2022 Q3	$0	Hold	9	–	–	﹤0.01%	4272
2022 Q2	$0	Buy	+9	New	+$144	﹤0.01%	4177
2018 Q1	–	Sell	-23	Closed	-$1K	–	1564
2017 Q4	$1K	Buy	+23	New	+$1.45K	﹤0.01%	1414

Carson Wealth (CWM LLC)'s ICPT Position: Q4 2023 in Review

Carson Wealth (CWM LLC) sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 13 shares.

Carson Wealth (CWM LLC) first reported a position in ICPT in Q4 2017 and held it in 6 quarters. The position peaked at $1K in Q1 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

Carson Wealth (CWM LLC) reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
Carson Wealth (CWM LLC) sold 13 Intercept Pharmaceuticals, Inc. shares in Q4 2023.
Carson Wealth (CWM LLC) first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2017 and held it in 6 quarters.
Carson Wealth (CWM LLC)'s Intercept Pharmaceuticals, Inc. position peaked at $1K in Q1 2023.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q4 2023, filed 1 Feb 2024.